Compare TNYA & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | RAIL |
|---|---|---|
| Founded | 2016 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 261.9M |
| IPO Year | 2021 | 2005 |
| Metric | TNYA | RAIL |
|---|---|---|
| Price | $0.77 | $8.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 224.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.96 | ★ 134.94 |
| EPS | N/A | ★ 1.15 |
| Revenue | N/A | ★ $500,991,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | N/A | $30.90 |
| P/E Ratio | ★ N/A | $7.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $7.27 |
| 52 Week High | $2.35 | $14.90 |
| Indicator | TNYA | RAIL |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 50.90 |
| Support Level | $0.75 | $7.47 |
| Resistance Level | $0.80 | $10.14 |
| Average True Range (ATR) | 0.05 | 0.29 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 11.01 | 77.69 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.